 |
|
Chronic pain treatments work better together, says Queen's anesthesiologist
October 01, 2009People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs.
A new, federally-funded study by Queen's University researchers has found that taking the drugs together is a more effective treatment than taking either of them individually.
When given both an anti-seizure drug (gabapentin) and an antidepressant (nortriptyline), patients suffering from neuropathic pain caused by nerve damage or disease experienced less pain than when they took one or the other individually, reports Ian Gilron, director of Clinical Pain Research for Queen's Departments of Anesthesiology, and Pharmacology & Toxicology, and an anesthesiologist at Kingston General Hospital.
"It was also exciting to discover the effect of this combination on sleep interference," adds Dr. Gilron, noting that people rated sleep interference with the combined drugs as 1.0 on a scale of 10, compared to 2.2 when they took each drug individually. "That's a very important issue for this group of patients, whose debilitating, unrelenting pain often interferes with normal sleep."
This is the first time Dr. Gilron has been able to find a drug combination that also helps patients sleep better. An earlier trial investigated the effects of combining morphine - the other type of commonly prescribed drug for neuropathic pain - with the anti-seizure drug gabapentin. The patients' pain lessened significantly, but they still had as much trouble sleeping.
Dr. Gilron says it's important to understand how drugs interact, since 45 per cent of Canadians being treated for neuropathic pain take two or more pain drugs. There may also be safety issues. "We need more evidence from carefully conducted trials in support of each particular combination, and let the doctors and patients know about such results," Dr. Gilron stresses.
While this research focuses on two specific types of neuropathic pain - diabetic neuropathy and postherpetic neuralgia - the methodology could also be applied to the study of other chronic conditions such as cancer-related pain, spinal disk disease, and the pain experienced after chemotherapy and mastectomies, says Dr. Gilron.
Results of the study, funded by the Canadian Institutes of Health Research (CIHR), are published today in the international health journal, The Lancet.
"This is a very interesting and important result," says Dr. Jane Aubin, Scientific Director of CIHR's Institute of Musculoskeletal Health and Arthritis. "Many chronic pain sufferers don't sleep well, and they get caught in a vicious cycle in which less sleep equals more pain. Dr. Gilron's work offers new hope to Canadians desperate to put an end to this debilitating situation."
Also on the Queen's team are researchers Joan Bailey (Anesthesiology), Dongsheng Tu (Mathematics and Statistics), Ronald Holden (Psychology,) Robyn Houlden (Medicine); and Alan Jackson from the University of Manitoba.
Queen's University
"It was also exciting to discover the effect of this combination on sleep interference," adds Dr. Gilron, noting that people rated sleep interference with the combined drugs as 1.0 on a scale of 10, compared to 2.2 when they took each drug individually. "That's a very important issue for this group of patients, whose debilitating, unrelenting pain often interferes with normal sleep."
This is the first time Dr. Gilron has been able to find a drug combination that also helps patients sleep better. An earlier trial investigated the effects of combining morphine - the other type of commonly prescribed drug for neuropathic pain - with the anti-seizure drug gabapentin. The patients' pain lessened significantly, but they still had as much trouble sleeping.
Dr. Gilron says it's important to understand how drugs interact, since 45 per cent of Canadians being treated for neuropathic pain take two or more pain drugs. There may also be safety issues. "We need more evidence from carefully conducted trials in support of each particular combination, and let the doctors and patients know about such results," Dr. Gilron stresses.
While this research focuses on two specific types of neuropathic pain - diabetic neuropathy and postherpetic neuralgia - the methodology could also be applied to the study of other chronic conditions such as cancer-related pain, spinal disk disease, and the pain experienced after chemotherapy and mastectomies, says Dr. Gilron.
Results of the study, funded by the Canadian Institutes of Health Research (CIHR), are published today in the international health journal, The Lancet.
"This is a very interesting and important result," says Dr. Jane Aubin, Scientific Director of CIHR's Institute of Musculoskeletal Health and Arthritis. "Many chronic pain sufferers don't sleep well, and they get caught in a vicious cycle in which less sleep equals more pain. Dr. Gilron's work offers new hope to Canadians desperate to put an end to this debilitating situation."
Also on the Queen's team are researchers Joan Bailey (Anesthesiology), Dongsheng Tu (Mathematics and Statistics), Ronald Holden (Psychology,) Robyn Houlden (Medicine); and Alan Jackson from the University of Manitoba.
Queen's University
Neuropathic Pain Current Events and Neuropathic Pain News RSSMedical food reduces medical costs and use of anti-convulsant medication
Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription medical food.
50 millionth unique chemical substance recorded in CAS Registry
Chemical Abstracts Service (CAS), a division of the American Chemical Society, announced that on September 7 it recorded the 50 millionth substance in CAS REGISTRY, the world's most comprehensive and high-quality compendium of publicly disclosed chemical information.
Active ingredients in marijuana found to spread and prolong pain
Imagine that you're working on your back porch, hammering in a nail. Suddenly you slip and hit your thumb instead - hard. The pain is incredibly intense, but it only lasts a moment. After a few seconds (and a few unprintable words) you're ready to start hammering again.
Oxycodone effective against shingles pain
The painkiller oxycodone is effective at treating the acute pain of shingles, an illness that often causes severe pain which can become long-lasting and sometimes even permanent.
Medicinal marijuana effective for neuropathic pain in HIV
In a double-blind, placebo-controlled clinical trial to assess the impact of smoked medical cannabis, or marijuana, on the neuropathic pain associated with HIV, researchers at the University of California, San Diego School of Medicine found that reported pain relief was greater with cannabis than with a placebo.
Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength
Noncombat-related acute and recurrent chronic pain are the leading causes of soldier attrition in modern war, with the return-to-duty rate as low as 2 percent when these soldiers are treated outside the theaters of operation.
Smoked cannabis proven effective in treating neuropathic pain
Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more.
Study finds role of mid-brain in integrating heart and respiratory response to exercise
For almost one hundred years the brain's "central command" system - whose charge includes controlling the body's cardiorespiratory response to exercise - has been pursued.
New technique holds promise for reducing back surgery failure
Texas researchers believe that they have discovered how to prevent many cases of the most common problem encountered by patients undergoing spine surgery: failed back surgery syndrome (FBSS).
Major breakthrough in the mechanism of myelin formation
The group of Dr. Michel Cayouette, researcher at Institut de recherches cliniques de Montréal (IRCM), and Dr. Jonah Chan, collaborator at the University of Southern California, will publish in the next issue of the prestigious scientific journal Science, the results of their study that could have a major impact on the treatment of diseases such as multiple sclerosis, and peripheral neuropathies.
More Neuropathic Pain Current Events and Neuropathic Pain News Articles
|
Neuropathic Pain (Oxford Pain Management Library Series) by Michael Bennett (Author) Neuropathic pain is increasingly recognized as a chronic disabling condition. It is frequently thought of as harder to treat than other pain types, and it often results in a poorer quality of life. Around 30% of adults in the UK alone have some type of chronic pain and some estimates suggest that one in five of these will have symptoms of neuropathic pain. This second edition of the popular pocketbook has been fully updated to include recent developments in the diagnosis and management of neuropathic pain. It includes new chapters on the clinical assessment of neuropathic pain and the use of screening tools in its diagnosis. This edition also includes a new chapter focusing on neuropathic lower back pain, a newly emerging clinical entity which is thought to be the most prevalent type... | |
 |
Diabetic Peripheral Neuropathic Pain Guidelines Pocketcard : by International Guidelines Cntr The Diabetic Peripheral Neuropathic Pain GUIDELINES Pocketcard is endorsed by the American Society of Pain Educators (ASPE). This practical quick-reference tool contains screening, diagnostic, treatment algorithm, drug therapy, dosing information, patient monitoring and counseling points. |
 |
Experian Health Dual Combo Tens Unit and Muscle Stimulator System with Carrying Case, Electrodes, and Battery Included Amazing Pain Relief for Chronic Pain , Acute Pain , Back Pain , Fibromyalgia ,Sciatica, Osteo Arthritis and More by Experian Health Experian Health Dual Combo is the latest and best selling Tens/Muscle stimulator combo unit. New & improved !! Lighter and smaller for more discreet portability. Bring the chiropractors office home. See the same results with this little unit as units that cost ten times more. In addition to the 4 modes (tens) & 2 Modes (nmes) Experian Health Tens unit features a treatment timer,last setting recall, patient compliance monitor,parameter lock and amplitude control cover. The "Experian Health" Electrode TENS Muscle Stimulator Unit has a Strong and Powerful 100mA (Excellent Stimulation Intensity). Get two Synergistic Therapies in One - a TENS Unit and a Muscle Stimulator. Together they work to relieve acute and chronic pain, stress, tension, sports injuries, fibromyalgia ,rehabilitation and... |
![Introduction to Neuropathic Pain Assessment and Examination [VHS]](http://ecx.images-amazon.com/images/I/51WQ8K42P2L._SL160_.jpg) |
Introduction to Neuropathic Pain Assessment and Examination [VHS] Starring: Misha-Miroslav Backonja |
 |
Diabetic Peripheral Neuropathic Pain GUIDELINES Pocketcard: American Society of Pain Educators (2008) by International Guidelines Center The Diabetic Peripheral Neuropathic Pain GUIDELINES Pocketcard provides all that is needed to make accurate clinical decisions at the point of care including: Key Points; Assessment and Diagnosis Algorithm; Validated Pain Rating Scales; Patient Foot Care; Modification of Therapy; Current Medication Tables with Brand and Generic Names; Detailed drug information - strengths, formulations, comments. |
 |
Emerging Strategies for the Treatment of Neuropathic Pain by James N., M.D. Campbell (Editor), Allan I., Ph.D. Basbaum (Editor), Andre, Ph.D. Dray (Editor), Ronald Dubner (Editor), Robert H. Dworkin (Editor), Christine N., M.D. Sang (Editor) |
 |
Striking Back (Striking Back The Trigeminal Neuralgia and Face Pain Handbook 2004) by George Weigel (Author) Published by TNA in 2004 and authored by George Weigel and Kenneth F. Casey, M.D., this handbook is written in layman's terms, describes all aspects of trigeminal neuralgia (TN) and facial pain, and provides vital information and resources for patients, family, friends and healthcare professionals. A must-have guide for every facial pain patient! |
 |
BIOFREEZE COMBO PACK - Two 3 oz. roll-on and One 16 oz. Pump by BIOFREEZE BIOFREEZE® is a unique, effective analgesic formulated to provide a variety of benefits for therapy, pain relief, exercise/training soreness and aid in overall comfort. BIOFREEZE® contains ILEX, an herbal extract from a South American holly shrub. ILEX is used around the world in various health & wellness formulations. BIOFREEZE® does not use waxes, oils, aloe or petroleum. The result is a fast-acting, deep penetrating, long lasting pain reliever |
 |
End the Pain - Neuropathic Facial Pain Expressions and Impressions by Suzanne Grenell (Editor) People of all ages in all parts of the world suffer neuropathic facial pain, including trigeminal neuralgia (TN), which strikes like lightning bolts in the face. The pain drives victims to their knees, to despair and sometimes suicide. This collection of poetry features very personal expressions of pain, coping, and great courage from sufferers and their loved ones. |
 |
Neuropathic Pain: From Bench to Bedside (International Congress and Symposium) by Martin, M.D. Koltzenburg (Editor), John Scadding (Editor) Univ. College, London, UK. Text from symposium held at the Royal Society of Medicine, London, UK, on Jan. 21, 2005. Text summarizes understanding of neuropathic pain. Topics include pathophysiology of painful peripheral neuropathies, functional imaging and plasticity, and more. For practitioners. Softcover. |
| © 2009 BrightSurf.com |